Alpha-methylacyl-CoA racemase is expressed in a majority of pancreatic neoplasms of neuroendocrine, acinar, and solid pseudopapillary differentiation
Author:
- 1 August 2015
- Vol. 47 (5) , 466-468
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Best Practices Recommendations in the Application of Immunohistochemistry in the ProstateAmerican Journal of Surgical Pathology, 2014
- α-Methylacyl-CoA racemase (P504S) is a useful marker for the differential diagnosis of solid pseudopapillary neoplasm of the pancreasAnnals of Diagnostic Pathology, 2014
- α-Methylacyl-CoA racemase (AMACR): Metabolic enzyme, drug metabolizer and cancer marker P504SProgress in Lipid Research, 2013
- Alpha-methylacyl-coenzyme A racemase expression in neuroendocrine neoplasms of the stomachVirchows Archiv, 2012
- Identification of prognostic biomarkers for glioblastomas using protein expression profilingInternational Journal of Oncology, 2011
- Towards a knowledge-based Human Protein AtlasNature Biotechnology, 2010
- Gene expression profiling provides insights into the pathways involved in solid pseudopapillary neoplasm of the pancreasThe Journal of Pathology, 2009
- α-Methylacyl CoA Racemase in Pulmonary Adenocarcinoma, Squamous Cell Carcinoma, and Neuroendocrine Tumors: Expression and Survival AnalysisArchives of Pathology & Laboratory Medicine, 2007
- Abundant expression of AMACR in many distinct tumour typesPathology, 2006
- Expression of α-methylacyl-coa racemase (p504s) in various malignant neoplasms and normal tissues: a study of 761 casesHuman Pathology, 2003